Evaluation of the Performance of Investigational Contact Lenses in a Presbyopic Population
Public ClinicalTrials.gov record NCT01763047. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the performance of a novel multifocal lens system.
Study identification
- NCT ID
- NCT01763047
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 298 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2012
- Primary completion
- Jan 31, 2013
- Completion
- Jan 31, 2013
- Last update posted
- Jun 18, 2018
2012 – 2013
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mission Viejo | California | — | — |
| RPS | Jacksonville | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Saint Augustine | Florida | — | — |
| Not listed | Tallahassee | Florida | — | — |
| Not listed | Winter Park | Florida | — | — |
| Not listed | Roswell | Georgia | — | — |
| Not listed | Lutherville | Maryland | — | — |
| Not listed | Closter | New Jersey | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Denver | North Carolina | — | — |
| Not listed | Athens | Ohio | — | — |
| Not listed | Kingston | Pennsylvania | — | — |
| Not listed | Warwick | Rhode Island | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Amarillo | Texas | — | — |
| Not listed | Tyler | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Salem | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01763047, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2018 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01763047 live on ClinicalTrials.gov.